| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |